HIV Now: New and Emerging First-line ART Strategies

Expert faculty provide insights on the latest data from studies evaluating recently approved and newly emerging regimens for first-line ART and assess how these new options may fit into evolving HIV treatment paradigms.
Eric S. Daar, MD
Daniel R. Kuritzkes, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 426 KB
Released: December 19, 2018


Provided by Annenberg Center for Health Sciences at Eisenhower

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Alma Perez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)

Supported by an educational grant from
Gilead Sciences

Related Content

Expert picks on key HIV data from CROI 2019, including pre-exposure prophylaxis (PrEP), first-line ART or switch, and treatment during pregnancy

Released: March 22, 2019

Results from DolPHIN-2 trial comparing dolutegravir- vs efavirenz-based ART in late pregnancy from CROI 2019 as reported by Clinical Care Options.

Released: March 8, 2019

Clinical Care Options slides. Expert insight on optimizing ART in newly diagnosed, stably suppressed, or treatment-experienced persons with HIV.

Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD, FIDSA, MACP
Program Director
Paul E. Sax, MD
Released: March 8, 2019

Latest report from NICHD P1081 study of raltegravir vs efavirenz in pregnant HIV-infected women at CROI 2019 as reported by Clinical Care Options HIV

Released: March 7, 2019

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the,, and Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?